Roche pRED (Pharma Research and Early Development) is one of four divisions within the Roche Group that make up the company's research and early development activities.

Roche pRED’s scientific work is organized within Discovery & Translational Medicine Areas (DTAs). Currently, the areas of focus include Immunology and Inflammation; Infectious Diseases; Neuroscience, Ophthalmology and Rare Diseases; and Oncology.

The pRED community is made up of more than 2,200 scientists spanning the globe from Europe to North America and Asia.